Aravive, Inc.
ARAV · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $9 | $7 | $6 | $5 |
| % Growth | 22.8% | 30.9% | 19.6% | – |
| Cost of Goods Sold | $67 | $38 | $18 | $13 |
| Gross Profit | -$58 | -$30 | -$12 | -$8 |
| % Margin | -632.6% | -404.4% | -209.9% | -170.1% |
| R&D Expenses | $67 | $38 | $18 | $13 |
| G&A Expenses | $13 | $11 | $13 | $14 |
| SG&A Expenses | $13 | $11 | $13 | $14 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$5 | $1 | -$0 | $3 |
| Operating Expenses | $80 | $48 | $31 | $27 |
| Operating Income | -$71 | -$41 | -$31 | -$22 |
| % Margin | -775.3% | -546.2% | -541.5% | -458.1% |
| Other Income/Exp. Net | -$5 | $1 | $0 | $4 |
| Pre-Tax Income | -$76 | -$39 | -$31 | -$18 |
| Tax Expense | $5 | -$1 | $4 | $2 |
| Net Income | -$81 | -$38 | -$34 | -$20 |
| % Margin | -885.6% | -512.5% | -602.3% | -426.1% |
| EPS | -2.22 | -1.9 | -2.17 | -1.75 |
| % Growth | -16.8% | 12.4% | -24% | – |
| EPS Diluted | -2.22 | -1.9 | -2.17 | -1.75 |
| Weighted Avg Shares Out | 36 | 20 | 16 | 12 |
| Weighted Avg Shares Out Dil | 36 | 20 | 16 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $1 |
| Interest Expense | $5 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $12 | $4 |
| EBITDA | -$71 | -$41 | -$19 | -$18 |
| % Margin | -775.3% | -546.2% | -338% | -383.3% |